☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
six
Kamada Collaborates with Alvotech to Commercialize its Six Biosimilar Products in Israel
December 3, 2019
Merck Reports FDA's Acceptance of sBLA of Keytruda (pembrolizumab) with Six-Week Dosing Schedule for Multiple Indications
July 9, 2019
AliveCor's KardiaMobile 6L Receives FDA's Clearance as Six-Lead Personal ECG Device
May 14, 2019
Load more...
Back to Home
Modal title
×
Modal body text goes here.
